Skip to main navigation Skip to search Skip to main content

Omega-3 Fatty Acid Dietary Supplements Consumed during Pregnancy and Lactation and Child Neurodevelopment: A Systematic Review

  • Julie E.H. Nevins
  • , Sharon M. Donovan
  • , Linda Snetselaar
  • , Kathryn G. Dewey
  • , Rachel Novotny
  • , Jamie Stang
  • , Elsie M. Taveras
  • , Ronald E. Kleinman
  • , Regan L. Bailey
  • , Ramkripa Raghavan
  • , Sara R. Scinto-Madonich
  • , Sudha Venkatramanan
  • , Gisela Butera
  • , Nancy Terry
  • , Jean Altman
  • , Meghan Adler
  • , Julie E. Obbagy
  • , Eve E. Stoody
  • , Janet De Jesus

Research output: Contribution to journalReview articlepeer-review

Abstract

Background: Maternal nutrition during pregnancy and lactation has profound effects on the development and lifelong health of the child. Long-chain PUFAs are particularly important for myelination and the development of vision during the perinatal period. Objectives: We conducted a systematic review to examine the relationship between supplementation with omega-3 fatty acids during pregnancy and/or lactation and neurodevelopment in children, to inform the Scientific Report of the 2020 Dietary Guidelines Advisory Committee. Methods: We identified articles on omega-3 fatty acid supplementation in pregnant and lactating women that included measures of neurodevelopment in their children (0-18 y) by searching PubMed, CENTRAL, Embase, and CINAHL Plus. After dual screening articles for inclusion, we qualitatively synthesized and graded the strength of evidence using pre-established criteria for assessing risk of bias, consistency, directness, precision, and generalizability. Results: We included 33 articles from 15 randomized controlled trials (RCTs) and 1 prospective cohort study. Of the 8 RCTs that delivered omega-3 fatty acid dietary supplements during pregnancy alone (200-2200 mg/d DHA and 0-1100 mg/d EPA for approximately 20 wk), 5 studies reported ≥1 finding that supplementation improved measures of cognitive development in the infant or child by 6%-11% (P < 0.05), but all 8 studies also reported ≥1 nonsignificant (P > 0.05) result. There was inconsistent or insufficient evidence for other outcomes (language, social-emotional, physical, motor, or visual development; academic performance; risks of attention deficit disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, anxiety, or depression) and for supplementation during lactation or both pregnancy and lactation. Populations with a lower socioeconomic status and adolescents were underrepresented and studies lacked racial and ethnic diversity. Conclusions: Limited evidence suggests that omega-3 fatty acid supplementation during pregnancy may result in favorable cognitive development in the child. There was insufficient evidence to evaluate the effects of omega-3 fatty acid supplementation during pregnancy and/or lactation on other developmental outcomes.

Original languageEnglish (US)
Pages (from-to)3483-3494
Number of pages12
JournalJournal of Nutrition
Volume151
Issue number11
DOIs
StatePublished - Nov 1 2021

Keywords

  • anxiety
  • attention deficit disorder
  • attention-deficit hyperactivity disorder
  • autism spectrum disorder
  • cognition
  • depression
  • lactation
  • omega-3 fatty acids
  • pregnancy
  • systematic review

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint

Dive into the research topics of 'Omega-3 Fatty Acid Dietary Supplements Consumed during Pregnancy and Lactation and Child Neurodevelopment: A Systematic Review'. Together they form a unique fingerprint.

Cite this